• Day, M., Wang, Z., Ding, J., An, X., Ingham, C.A., Shering, A.F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A.R., Mugnaini, E., Deutch, A.Y., Sesack, S.R., Arbuthnott, G.W. & Surmeier, D.J. (2006) Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci., 9, 251259.
  • Neely, M.D., Schmidt, D.E. & Deutch, A.Y. (2007) Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience, 149, 457464.
  • Scholz, B., Svensson, M., Alm, H., Skold, K., Falth, M., Kultima, K., Guigoni, C., Doudnikoff, E., Li, Q., Crossman, A.R., Bezard, E. & Andren, P.E. (2008) Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure. PLoS ONE, 3, e1589.
  • Schuster, S., Doudnikoff, E., Rylander, D., Berthet, A., Aubert, I., Ittrich, C., Bloch, B., Cenci, M.A., Surmeier, D.J., Hengerer, B. & Bezard, E. (2009) Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol. Psychiatry, 65, 518526.
  • Soderstrom, K.E., O’Malley, J.A., Levine, N.D., Sortwell, C.E., Collier, T.J. & Steece-Collier, K. (2010) Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur. J. Neurosci., 31, 478490.